A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
Public ClinicalTrials.gov record NCT06399718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
BOTOX® (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Study identification
- NCT ID
- NCT06399718
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Interventions
- BOTOX Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2024
- Primary completion
- Nov 9, 2025
- Completion
- Nov 9, 2025
- Last update posted
- Nov 16, 2025
2024 – 2025
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Westside Aesthetics /ID# 248232 | Los Angeles | California | 90025-1708 | — |
| Private Practice - Dr. Steven G. Yoelin /ID# 268046 | Newport Beach | California | 92663 | — |
| Pacific Clinical Innovations /ID# 248231 | Vista | California | 92083-6030 | — |
| Sherber + RAD /ID# 248894 | Washington D.C. | District of Columbia | 20005-5002 | — |
| Steven Fagien MD Aesthetic Eyelid Plastic Surgery /ID# 248478 | Boca Raton | Florida | 33431-6465 | — |
| Skin Research Institute LLC /ID# 248230 | Coral Gables | Florida | 33146-1837 | — |
| Kavali Plastic Surgery and Skin Renewal Center /ID# 248480 | Atlanta | Georgia | 30328 | — |
| DeNova Research /ID# 248237 | Chicago | Illinois | 60610 | — |
| DelRicht Research /ID# 250313 | Baton Rouge | Louisiana | 70809 | — |
| Etre Cosmetic Dermatology and Laser Center /ID# 248229 | New Orleans | Louisiana | 70130-4353 | — |
| Aesthetic Center at Woodholme /ID# 248481 | Baltimore | Maryland | 21208-6391 | — |
| Michigan Center for Research Corporation /ID# 249145 | Clinton Township | Michigan | 48038 | — |
| Skin Specialists /ID# 248233 | Omaha | Nebraska | 68144 | — |
| Laser & Skin Surgery Center of New York /ID# 248479 | New York | New York | 10016-4974 | — |
| Luxurgery /ID# 248236 | New York | New York | 10021 | — |
| The Practice of Brian S. Biesman MD PLLC /ID# 248226 | Nashville | Tennessee | 37203 | — |
| Sherman Aesthetic Center /ID# 248482 | Nashville | Tennessee | 37205-2205 | — |
| Westlake Dermatology & Cosmetic Surgery - Westlake /ID# 249875 | Austin | Texas | 78746-4720 | — |
| DermResearch Inc. /ID# 248227 | Austin | Texas | 78759 | — |
| Austin Institute for Clinical Research at SBA Dermatology /ID# 248228 | Houston | Texas | 77056-4129 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06399718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06399718 live on ClinicalTrials.gov.